Compare SYRE & FBRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SYRE | FBRT |
|---|---|---|
| Founded | 2013 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 882.8M |
| IPO Year | 2016 | 1985 |
| Metric | SYRE | FBRT |
|---|---|---|
| Price | $33.59 | $10.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $55.50 | $14.75 |
| AVG Volume (30 Days) | ★ 745.7K | 644.3K |
| Earning Date | 11-04-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 13.27% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.80 |
| Revenue | N/A | ★ $241,051,000.00 |
| Revenue This Year | N/A | $28.41 |
| Revenue Next Year | N/A | $50.77 |
| P/E Ratio | ★ N/A | $13.39 |
| Revenue Growth | N/A | ★ 32.77 |
| 52 Week Low | $10.91 | $9.71 |
| 52 Week High | $35.31 | $13.58 |
| Indicator | SYRE | FBRT |
|---|---|---|
| Relative Strength Index (RSI) | 69.14 | 64.23 |
| Support Level | $33.24 | $10.48 |
| Resistance Level | $35.31 | $10.68 |
| Average True Range (ATR) | 1.79 | 0.16 |
| MACD | 0.16 | 0.06 |
| Stochastic Oscillator | 79.12 | 92.36 |
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. Its segments include the real estate debt business; the real estate securities business; the real estate owned business; and the commercial real estate conduit business.